<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:media="http://search.yahoo.com/mrss/"><channel><title>Zibb.com: Abbott Laboratories (Web)</title><link>http://www.zibb.com/healthcare/theme/cq/Abbott+Laboratories</link><atom:link rel="self" type="application/rss+xml" href="http://www.zibb.com/healthcare/theme/cq/Abbott+Laboratories" /><description>
					Zibb. The Global business search engine.
				</description><language>
					en-US
				</language><webMaster>search@zibb.com (RB Search)</webMaster><copyright>Copyright (c) 2007 Reed Business Information. All rights reserved.</copyright><pubDate>Mon, 28 Jan 2008 00:00:00 GMT</pubDate><lastBuildDate>Mon, 28 Jan 2008 00:00:00 GMT</lastBuildDate><ttl>60</ttl><image><title>Zibb.com: Abbott Laboratories (Web)
          </title><width>88</width><height>31</height><link>http://www.zibb.com/healthcare/theme/cq/Abbott+Laboratories</link><url>
						http://www.zibb.com/images/en/g_zibb_logo_beta.gif
					</url></image><item><title>Abbott Laboratories Biotech Facility</title><link>http://www.pharmaceutical-technology.com/projects/puertorico/</link><description>News and project information on the Abbott Laboratories Biotech Facility, Barceloneta</description><guid>http://www.pharmaceutical-technology.com/projects/puertorico/</guid><category domain="http://www.zibb.com">Abbott Laboratories</category><pubDate>Mon, 28 Jan 2008 00:00:00 GMT</pubDate><source url="http://www.pharmaceutical-technology.com" /></item><item><title>Abbott Labs: Global Health Care &amp; Medical Research</title><link>http://www.abbott.com/</link><description>Welcome To The Family: Abbott Medical Optics Joins Our Team The initials are the same, but the 3,600 employees of AMO, formerly Advanced Medical Optics, are now part of Abbott as the transaction to acquire this established global leader in vision care has been completed.</description><guid>http://www.abbott.com/</guid><category domain="http://www.zibb.com">Abbott Laboratories</category><pubDate /><source url="http://www.abbott.com" /></item><item><title>CLAVE®Connector</title><link>http://www.icumed.com/CLAVE_FAQS.asp</link><description>The CLAVE Connector is an exclusive proprietary product manufactured by ICU Medical which is available through Abbott Laboratories and independent international specialty distributors.</description><guid>http://www.icumed.com/CLAVE_FAQS.asp</guid><category domain="http://www.zibb.com">Abbott Laboratories</category><pubDate /><source url="http://www.icumed.com" /></item><item><title>Innogenetics - Administration</title><link>http://www.innogenetics.com/site/pressview.asp?id=101&amp;lang=E</link><description>Gent (Belgium) – July 12, 2002 - Innogenetics announced today a new distribution arrangement, whereby the Innogenetics’ LiPA HLA tissue typing products will be marketed worldwide by both Innogenetics and Abbott Laboratories.</description><guid>http://www.innogenetics.com/site/pressview.asp?id=101&amp;lang=E</guid><category domain="http://www.zibb.com">Abbott Laboratories</category><pubDate /><source url="http://www.innogenetics.com" /></item><item><title>Kalido - Kalido Customer Abbott Laboratories Named to InfoWorld 1...
      </title><link>http://www.newsrx.com/health-articles/791922.html</link><description>With over 65,000 employees and products in more than 130 countries, Abbott's International division needed a better handle on international sales and margin data to foster continued growth.</description><guid>http://www.newsrx.com/health-articles/791922.html</guid><category domain="http://www.zibb.com">Abbott Laboratories</category><pubDate /><source url="http://www.newsrx.com" /></item><item><title>Valera Pharmaceuticals - Media Center</title><link>http://www.hydromed.com/press_view.asp?id=59</link><description>Cranbury, N.J., April 11, 2005 – Valera Pharmaceuticals today announced the appointment of Andrew T. Drechsler to the newly created position of Chief Financial Officer. The company noted that Mr.</description><guid>http://www.hydromed.com/press_view.asp?id=59</guid><category domain="http://www.zibb.com">Abbott Laboratories</category><pubDate /><source url="http://www.hydromed.com" /></item><item><title>Hospira</title><link>http://www.hospira.com/NewsAndMediaCenter/financialpressreleases.aspx</link><description>Site contents are intended for informational purposes only and not intended to replace discussion with a healthcare provider. If you have any questions regarding this site, contact Hospira.</description><guid>http://www.hospira.com/NewsAndMediaCenter/financialpressreleases.aspx</guid><category domain="http://www.zibb.com">Abbott Laboratories</category><pubDate /><source url="http://www.hospira.com" /></item><item><title>Idenix Pharmaceuticals: Thomas R. Hodgson</title><link>http://www.idenix.com/about/bio_hodgson.html</link><description>Thomas R. Hodgson has served as a director since February 2002. From September 1990 to January 1999, Mr. Hodgson served as the president and chief operating officer of Abbott Laboratories. From 1983 to 1990, Mr. Hodgson served as the president of Abbott International and from 1978 to 1983, Mr.</description><guid>http://www.idenix.com/about/bio_hodgson.html</guid><category domain="http://www.zibb.com">Abbott Laboratories</category><pubDate /><source url="http://www.idenix.com" /></item><item><title>Ross.com - Reimbursement</title><link>http://www.ross.com/reimbursement/rates.asp</link><description>NOTE: Information contained in this section and in the state summaries is taken from a variety of sources including, but not limited to, official state documents, as well as verbal and written reports from individuals inside and outside of the various state government offices.</description><guid>http://www.ross.com/reimbursement/rates.asp</guid><category domain="http://www.zibb.com">Abbott Laboratories</category><pubDate /><source url="http://www.ross.com" /></item><item><title>Protherics : Enfer agrees deal with Abbott Laboratories for Inter...
      </title><link>http://www.protherics.com/News/news-item_207.aspx</link><description>Enfer Scientific Ltd has signed an agreement for Abbott Laboratories to undertake the international distribution of the Protherics/Enfer post-mortem BSE test-kit.</description><guid>http://www.protherics.com/News/news-item_207.aspx</guid><category domain="http://www.zibb.com">Abbott Laboratories</category><pubDate /><source url="http://www.protherics.com" /></item><item><title>Apria - resources - News</title><link>http://www.apria.com/resources/1,2725,494-859692,00.html</link><description>LONDON, Dec 12 (Reuters) - Irish drug maker Elan Corp PLC on Friday announced plans to save $20 million to $25 million by shedding 114 jobs and closing its Tokyo and New York offices as a major shareholder called for its top executive to step down.</description><guid>http://www.apria.com/resources/1,2725,494-859692,00.html</guid><category domain="http://www.zibb.com">Abbott Laboratories</category><pubDate /><source url="http://www.apria.com" /></item><item><title>Abbott Laboratories to pay $28 million to settle lawsuit brought ...
      </title><link>http://www.compare-prices.net/node/6762</link><description>Abbott Laboratories will pay Texas $28 million to settle a lawsuit claiming that the drugmaker falsely reported drug prices to Medicaid programs, Texas Attorney General Greg Abbott said Tuesday. Abott Laboratories, based in Abbott Park, Ill.</description><guid>http://www.compare-prices.net/node/6762</guid><category domain="http://www.zibb.com">Abbott Laboratories</category><pubDate /><source url="http://www.compare-prices.net" /></item><item><title>Pharmacy Choice - Pharmaceutical News - Biovail Seeks FDA Approva...
      </title><link>http://www.pharmacychoice.com/redirect.cfm?track_id=1674</link><description>September 4, 2008 (FinancialWire) -- Canadian drugmaker Biovail Corp. (NYSE: BVF) said that it is seeking U.S. approval to market a generic version of cholesterol drug Tricor from Abbott Laboratories (NYSE: ABT).</description><guid>http://www.pharmacychoice.com/redirect.cfm?track_id=1674</guid><category domain="http://www.zibb.com">Abbott Laboratories</category><pubDate /><source url="http://www.pharmacychoice.com" /></item><item><title>Abbott Laboratories News - Healthcare Industry Today</title><link>http://health.einnews.com/news/abbott-laboratories</link><description>Abbott Laboratories News. Service for global professionals. Constantly updated news and information about health.</description><guid>http://health.einnews.com/news/abbott-laboratories</guid><category domain="http://www.zibb.com">Abbott Laboratories</category><pubDate /><source url="http://health.einnews.com" /></item><item><title>Abbott Laboratories Increases Its Commitment to Diabetes Camps an...
      </title><link>http://www.medicalnewsservice.com/fullstory.cfm?storyID=2479&amp;fback=yes</link><description>Donations received as part of the scholarship program have allowed more than 300 children the opportunity to go to camp, and will total more than $350,000 at the program's five-year anniversary in 2004.</description><guid>http://www.medicalnewsservice.com/fullstory.cfm?storyID=2479&amp;fback=yes</guid><category domain="http://www.zibb.com">Abbott Laboratories</category><pubDate /><source url="http://www.medicalnewsservice.com" /></item><item><title>Axis-Shield News</title><link>http://www.axis-shield.com/news/141/newsartpage</link><description>Axis-Shield plc (“Axis-Shield”) today (Friday 23 November 2001) announces that it has signed an agreement with Abbott Laboratories, under which Axis-Shield will develop and manufacture a test for testosterone in human serum.</description><guid>http://www.axis-shield.com/news/141/newsartpage</guid><category domain="http://www.zibb.com">Abbott Laboratories</category><pubDate /><source url="http://www.axis-shield.com" /></item><item><title>Abbott Laboratories and UK firm collaboration hits $1bn sales</title><link>http://www.allaboutmedicalsales.com/news/0106/Abbott_Laboratories_27.html</link><description>Date published: 27/01/2006 The collaboration between Abbott Laboratories and UK firm Cambridge Antibody Technology (CAT) has resulted in $1.4 billion worth of sales.</description><guid>http://www.allaboutmedicalsales.com/news/0106/Abbott_Laboratories_27.html</guid><category domain="http://www.zibb.com">Abbott Laboratories</category><pubDate /><source url="http://www.allaboutmedicalsales.com" /></item><item><title>MedImmune | About | Strategic Alliances</title><link>http://www.aviron.com/about/company/alliances.asp</link><description>Abbott Laboratories MedImmune entered into an international distribution agreement with Abbott International, an affiliate of Abbott, to distribute Synagis® (palivizumab) and when and if approved, motavizumab (formerly known as Numax®) outside of the United States.</description><guid>http://www.aviron.com/about/company/alliances.asp</guid><category domain="http://www.zibb.com">Abbott Laboratories</category><pubDate /><source url="http://www.aviron.com" /></item><item><title>IndustrialLaboratories.com | Industrial Laboratories | III Clinic...
      </title><link>http://www.industriallaboratories.com/related/clinical-trial-database.htm?tkn=8JeCIMDMmAcKEwiy7_a77fqXAhUaFmsKHc4t3FQYASABMIiRqAM4DVCIkagDUOTaxAlQy7qLD1DPt7URUPHeiiFQh8mJ1QE</link><description>Clinical Trial Network Provides a searchable database of clinical investigators to sponsor companies, CROs, and individuals looking to participate in clinical trials. www.clinicaltrialnetwork.com/</description><guid>http://www.industriallaboratories.com/related/clinical-trial-database.htm?tkn=8JeCIMDMmAcKEwiy7_a77fqXAhUaFmsKHc4t3FQYASABMIiRqAM4DVCIkagDUOTaxAlQy7qLD1DPt7URUPHeiiFQh8mJ1QE</guid><category domain="http://www.zibb.com">Abbott Laboratories</category><pubDate /><source url="http://www.industriallaboratories.com" /></item><item><title>Abbott Labs Accused of Drug Pricing Fraud</title><link>http://healthinsurance.about.com/b/a/256783.htm</link><description>These charges were initially filed by a whistleblower company, but the U.S. Department of Justice has joined as a plaintiff against defendant Abbott Labs. It will be interesting to see how or whether this case affects the way drug manufacturers price their medication in the future.</description><guid>http://healthinsurance.about.com/b/a/256783.htm</guid><category domain="http://www.zibb.com">Abbott Laboratories</category><pubDate /><source url="http://healthinsurance.about.com" /></item><item><title>EntreMed, Inc. Files Counterclaims Against Abbott Laboratories to...
      </title><link>http://www.entremed.com/go.cfm?do=Press.ViewArchive&amp;prid=13</link><description>ROCKVILLE, MD, July 18 -- EntreMed, Inc. (Nasdaq: ENMD) has filed legal papers to protect its exclusive rights to a key molecule that contains antiangiogenic activity.</description><guid>http://www.entremed.com/go.cfm?do=Press.ViewArchive&amp;prid=13</guid><category domain="http://www.zibb.com">Abbott Laboratories</category><pubDate /><source url="http://www.entremed.com" /></item><item><title>ISA | Abbott Labs deals for Kos</title><link>http://www.isa.org/InTechTemplate.cfm?Section=Industry_News&amp;template=/ContentManagement/ContentDisplay.cfm&amp;ContentID=57218</link><description>Kos’ main product is Niaspan, which raises levels of “good,” or HDL, cholesterol. The company also makes Advicor, a Niaspan combination drug that treats patients with multiple lipid disorders.</description><guid>http://www.isa.org/InTechTemplate.cfm?Section=Industry_News&amp;template=/ContentManagement/ContentDisplay.cfm&amp;ContentID=57218</guid><category domain="http://www.zibb.com">Abbott Laboratories</category><pubDate /><source url="http://www.isa.org" /></item><item><title>ArthritisSupport.com 03-19-2003 Abbott Laboratories, maker of the...
      </title><link>http://www.arthritissupport.com/library/print.cfm?ID=682&amp;t=Arthritis</link><description>ArthritisSupport.com 03-19-2003 Abbott Laboratories, maker of the new rheumatoid arthritis drug Humira™, (adalimumab) recently announced the expansion of two clinical trials evaluating the potential of Humira in psoriasis and psoriatic arthritis.</description><guid>http://www.arthritissupport.com/library/print.cfm?ID=682&amp;t=Arthritis</guid><category domain="http://www.zibb.com">Abbott Laboratories</category><pubDate /><source url="http://www.arthritissupport.com" /></item><item><title>LifeScan Diabetes Press Releases -- New Initiative Provides Ameri...
      </title><link>http://www.lifescan.com/company/about/together_rx/</link><description>The Together Rx Access™ Card provides savings of about 25 to 40 percent, and sometimes more, on more than 275 brand name prescription drugs and other prescription products, including most of the prescription medicines made by the Johnson &amp; Johnson U.S operating companies.</description><guid>http://www.lifescan.com/company/about/together_rx/</guid><category domain="http://www.zibb.com">Abbott Laboratories</category><pubDate /><source url="http://www.lifescan.com" /></item><item><title>Radiology, Links</title><link>http://www.lumisys.com/index.asp?sec=lin&amp;sub=def&amp;eid=10986</link><description>AuntMinnie.com lin AllAuntMinnie Articles Case of the Day Job Boards Open Market Buyer's Guide Forums Links Conferences Equipment Classifieds |Home|Buyer's Guide|Career Center|Reference|Marketplace|Education|Conferences|Links|Communities|Forums|Media| [Sign in] [Register for Free!] [Newsletters]</description><guid>http://www.lumisys.com/index.asp?sec=lin&amp;sub=def&amp;eid=10986</guid><category domain="http://www.zibb.com">Abbott Laboratories</category><pubDate /><source url="http://www.lumisys.com" /></item></channel></rss>